Hims & Hers Health Inc [HIMS] stock prices are down -0.06% to $30.87 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HIMS shares have gain 10.49% over the last week, with a monthly amount glided 17.82%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on January 10, 2025, when Citigroup downgraded its rating to a Sell and also boosted its price target to $25 from $24. Previously, BTIG Research started tracking the stock with Buy rating on January 07, 2025, and set its price target to $35. On December 17, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $42 on the stock. BofA Securities downgraded its rating to a Underperform. Needham initiated its recommendation with a Buy and recommended $24 as its price target on August 22, 2024. Imperial Capital downgraded its rating to In-line for this stock on August 09, 2024. In a note dated May 22, 2024, Citigroup downgraded an Neutral rating on this stock and boosted its target price from $16 to $20.
The stock price of Hims & Hers Health Inc [HIMS] has been fluctuating between $8.51 and $35.02 over the past year. Currently, Wall Street analysts expect the stock to reach $24.67 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $30.87 at the most recent close of the market. An investor can expect a potential drop of -20.08% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
The Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.24B for trailing twelve months, representing a surge of 77.13%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.27 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.32 points at the first support level, and at 29.78 for the second support level. However, for the 1st resistance point, the stock is sitting at 31.74, and for the 2nd resistance point, it is at 32.62.
Ratios To Look Out For
It’s worth pointing out that Hims & Hers Health Inc [NYSE:HIMS]’s Current Ratio is 2.14. Further, the Quick Ratio stands at 1.82, while the Cash Ratio is 1.08. Considering the valuation of this stock, the price to sales ratio is 5.43, the price to book ratio is 15.28 and price to earnings (TTM) ratio is 71.41.
Transactions by insiders
Recent insider trading involved Chi Michael, Chief Commercial Officer, that happened on Jan 24 ’25 when 17304.0 shares were sold. Chief Executive Officer, Dudum Andrew completed a deal on Jan 23 ’25 to sell 27098.0 shares. Meanwhile, Officer Chi Michael bought 17304.0 shares on Jan 24 ’25.
